CVS Health Corporation $CVS Shares Sold by Venture Visionary Partners LLC

Venture Visionary Partners LLC decreased its position in CVS Health Corporation (NYSE:CVS) by 11.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 10,013 shares of the pharmacy operator’s stock after selling 1,287 shares during the period. Venture Visionary Partners LLC’s holdings in CVS Health were worth $678,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. McIlrath & Eck LLC boosted its stake in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 174 shares during the last quarter. Costello Asset Management INC boosted its stake in shares of CVS Health by 281.3% during the first quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 422 shares during the last quarter. Stone House Investment Management LLC acquired a new stake in shares of CVS Health during the first quarter valued at $39,000. Park Square Financial Group LLC acquired a new stake in shares of CVS Health during the fourth quarter valued at $43,000. Finally, GW&K Investment Management LLC boosted its stake in shares of CVS Health by 39.4% during the first quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator’s stock valued at $43,000 after acquiring an additional 180 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on CVS. Morgan Stanley increased their price objective on CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Friday, August 1st. Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Bernstein Bank decreased their price target on CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research note on Wednesday, July 16th. Royal Bank Of Canada raised their price target on CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a research note on Monday, May 5th. Finally, Barclays raised their price target on CVS Health from $79.00 to $80.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $76.67.

CVS Health Stock Performance

CVS Health stock opened at $70.9160 on Thursday. The stock’s 50-day moving average is $65.33 and its 200-day moving average is $64.90. The company has a market cap of $89.94 billion, a price-to-earnings ratio of 19.81, a price-to-earnings-growth ratio of 0.78 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the business posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date was Tuesday, July 22nd. CVS Health’s dividend payout ratio (DPR) is 74.30%.

Insiders Place Their Bets

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director directly owned 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is currently owned by company insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.